Clinical Trials Browser

Has results × Topotecan × Tumor-Agnostic × Clear all

NCT00382733 2013-07-22

Oral Topotecan to Treat Recurrent or Persistent Solid Tumors

Phase 1/2 Completed

26 enrolled 8 charts

Neoplasms

NCT00611468 2011-08-22

Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid Tumors

Phase 1 Completed

29 enrolled 13 charts

Neoplasm Metastasis